Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration.

    Carrasco E, Hernández C, Miralles A, Huguet P, Farrés J, Simó R.

    Diabetes Care. 2007 Nov;30(11):2902-8. Epub 2007 Aug 17.PMID: 17704349 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation.

    Carrasco E, Hernández C, de Torres I, Farrés J, Simó R.

    Mol Vis. 2008 Aug 15;14:1496-502.PMID: 18709137 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects.

    García-Ramírez M, Hernández C, Simó R.

    Diabetes Care. 2008 Jun;31(6):1189-94. Epub 2008 Mar 10.PMID: 18332162 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Apolipoprotein A1 is overexpressed in the retina of diabetic patients.

    Simó R, García-Ramírez M, Higuera M, Hernández C.

    Am J Ophthalmol. 2009 Feb;147(2):319-325.e1. Epub 2008 Oct 9.PMID: 18848320 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.

    Garcia-Ramírez M, Hernández C, Villarroel M, Canals F, Alonso MA, Fortuny R, Masmiquel L, Navarro A, García-Arumí J, Simó R.

    Diabetologia. 2009 Oct 13. [Epub ahead of print]PMID: 19823802 [PubMed - as supplied by publisher]Related articles

    6.

    Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.

    Hernández C, Fonollosa A, García-Ramírez M, Higuera M, Catalán R, Miralles A, García-Arumí J, Simó R.

    Diabetes Care. 2006 Sep;29(9):2028-33.PMID: 16936148 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.

    Simó R, Higuera M, García-Ramírez M, Canals F, García-Arumí J, Hernández C.

    Arch Ophthalmol. 2008 Aug;126(8):1076-81.PMID: 18695102 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects.

    Hernández C, Carrasco E, Casamitjana R, Deulofeu R, García-Arumí J, Simó R.

    Diabetes Care. 2005 Aug;28(8):1941-7.PMID: 16043736 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.

    Simó R, Lecube A, Sararols L, García-Arumí J, Segura RM, Casamitjana R, Hernández C.

    Diabetes Care. 2002 Dec;25(12):2282-6.PMID: 12453974 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression.

    Catalani E, Cervia D, Martini D, Bagnoli P, Simonetti E, Timperio AM, Casini G.

    Eur J Neurosci. 2007 Mar;25(5):1447-59.PMID: 17425570 [PubMed - indexed for MEDLINE]Related articles

    11.

    Müller cell changes in human diabetic retinopathy.

    Mizutani M, Gerhardinger C, Lorenzi M.

    Diabetes. 1998 Mar;47(3):445-9.PMID: 9519752 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Human retinal pigment epithelium proteome changes in early diabetes.

    Decanini A, Karunadharma PR, Nordgaard CL, Feng X, Olsen TW, Ferrington DA.

    Diabetologia. 2008 Jun;51(6):1051-61. Epub 2008 Apr 15.PMID: 18414830 [PubMed - indexed for MEDLINE]Related articles

    13.

    Aldose reductase expression in human diabetic retina and retinal pigment epithelium.

    Vinores SA, Campochiaro PA, Williams EH, May EE, Green WR, Sorenson RL.

    Diabetes. 1988 Dec;37(12):1658-64.PMID: 3142801 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2.

    Layton CJ, Becker S, Osborne NN.

    Mol Vis. 2006 Jan 18;12:43-54.PMID: 16446701 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants.

    Lecleire-Collet A, Tessier LH, Massin P, Forster V, Brasseur G, Sahel JA, Picaud S.

    Br J Ophthalmol. 2005 Dec;89(12):1631-3.PMID: 16299145 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy.

    García-Ramírez M, Canals F, Hernández C, Colomé N, Ferrer C, Carrasco E, García-Arumí J, Simó R.

    Diabetologia. 2007 Jun;50(6):1294-303. Epub 2007 Mar 23.PMID: 17380318 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

    Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42.PMID: 18235022 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures.

    Vasilaki A, Papadaki T, Notas G, Kolios G, Mastrodimou N, Hoyer D, Tsilimbaris M, Kouroumalis E, Pallikaris I, Thermos K.

    Invest Ophthalmol Vis Sci. 2004 May;45(5):1499-506.PMID: 15111608 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.

    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.

    Int J Mol Med. 2008 Jun;21(6):667-76.PMID: 18506358 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.

    Miyamoto N, de Kozak Y, Jeanny JC, Glotin A, Mascarelli F, Massin P, BenEzra D, Behar-Cohen F.

    Diabetologia. 2007 Feb;50(2):461-70. Epub 2006 Dec 23.PMID: 17187248 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data